GlaxoSmithKline Pharmaceuticals Limited announces that the Dr. Shalini Menon has been appointed as Executive Vice President - Medical Affairs, effective 8 July 2024. She will be part of the Senior Management team of the Company. Further, Dr. Rashmi Hegde, current Executive Vice President - Medical Affairs would retire effective from 31 July 2024.

Dr. Shalini brings with her 18 years of experience in Medical Affairs with expertise and key contributions in strategic prelaunch planning and therapy shaping by addressing unmet needs, building strong cross-functional working relationships, team building, establishing trusted partnerships with external stakeholders and leading Diversity & Inclusion initiatives amongst others. Prior to joining GSK, she worked at Sanofi since 2015 and led the Medical team there as Country Medical Head for the last 6 years. Dr. Shalini began her career in 2006 at Pfizer and went on to role of Senior Medical Advisor and Lead, Clinical development.

She moved from Pfizer to Boehringer Ingelheim in 2011, to launch Diabetes portfolio as Head of Medical affairs, Diabetes & Medical Information She holds degrees in MBBS, MD, DNB in Pharmacology from Seth GS Medical college & KEM Hospital Mumbai. She also has a Masters in Pharmaceutical medicine from Hibernia University Dublin.